Phenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension, dilate the pupil, and induce local vasoconstriction. The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s.
Phenylephrine was granted FDA approval in 1939.
Phenylephrine is available in various drug formulations, which have different indications. Phenylephrine injections are indicated to treat hypotension caused by shock or anesthesia. The ophthalmic formulation is indicated to induce mydriasis and conjunctival vasoconstriction. The intranasal formulation is used to treat congestion, and a topical formulation is used to treat hemorrhoids. Off-label uses include priapism and induction of local vasoconstriction.
AZ Maria Middelares, Gent, Belgium
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Autonomic Dysfunction Center, Nashville, Tennessee, United States
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Aarhus University Hospital, Aarhus, Jylland, Denmark
New York University School of Medicine, New York, New York, United States
Radboudumc, Nijmegen, Gelderland, Netherlands
University of Calgary, Calgary, Alberta, Canada
Victoria Hospital, London, Ontario, Canada
Haeundae paik hospital, inje university, Busan, Korea, Republic of
Atlanta VA Medical Center, Decatur, Georgia, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.